Transaction in Own Shares

Summary by AI BETAClose X

Taylor Wimpey plc has announced the purchase of 5,623,124 ordinary shares between March 5th and March 11th, 2026, with a volume weighted average price of approximately 98.75 pence per share. These shares will be held in treasury, bringing the total held to 13,910,239, and leaving 3,543,074,864 shares in issue. This reduction in outstanding shares impacts the total number of voting rights available to shareholders for regulatory notification purposes.

Disclaimer*

Taylor Wimpey PLC
12 March 2026
 

 

 

 


12 March 2026

Taylor Wimpey plc

Transaction in Own Shares

 

Taylor Wimpey plc (the "Company") announces today that, acting through its corporate stockbroker, Citigroup Global Markets Limited (the "Broker"), it has purchased the following number of the Company's ordinary shares of 1 pence each in the period from 05 March 2026 to 11 March 2026.

Date

Number of shares purchased

Highest price paid (GBp)

Lowest price paid (GBp)

Volume weighted average price (GBp)

Trading Venue

05 March 2026

1,719,577

106.10

100.25

102.34

XLON

06 March 2026

1,161,759

101.95

98.06

99.63

XLON

09 March 2026

1,549,432

97.32

95.04

96.32

XLON

10 March 2026

1,157,289

100.25

98.02

99.01

XLON

11 March 2026

635,067

98.56

96.86

97.63

XLON

 

The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company holds 13,910,239 of its ordinary shares in treasury and has 3,543,074,864 shares in issue (excluding treasury shares).

Accordingly, the total number of voting rights in the Company will be 3,543,074,864. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

http://www.rns-pdf.londonstockexchange.com/rns/3081W_1-2026-3-11.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings